MIKAYLA CADMAN: Open Payments
NPI 1619749140 · MACUNGIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 65 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,009 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $229 |
| Otsuka America Pharmaceutical, Inc. | 6 | $197 |
| Radius Health, Inc. | 9 | $166 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Eisai Inc. | 7 | $144 |
| Braeburn Inc. | 6 | $100 |
| Phathom Pharmaceuticals, Inc. | 4 | $93 |
| Lilly USA, LLC | 3 | $51 |
| Biogen, Inc. | 2 | $45 |
| Dexcom, Inc. | 2 | $42 |
Products named: Wegovy, REXULTI, Leqembi, Tymlos, BRIXADI, VOQUEZNA, Dexcom G6 Transmitter, BREZTRI.
Industry payments across PA — which companies pay providers there.
